Skip to main
CI
CI logo

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 33%
Buy 60%
Hold 7%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is strategically positioned to capitalize on the rapidly growing biosimilars market, projected to reach $100 billion by 2030, enhancing its competitive advantage in the healthcare sector. The company’s innovative strategies, including the introduction of cost-sharing options and anticipated double-digit savings in GLP-1 net costs, are expected to provide substantial financial benefits to employer clients. Furthermore, the expansion of its Evernorth segment is anticipated to bolster earnings resilience during economic downturns, reflecting Cigna's ability to navigate challenging financial landscapes effectively.

Bears say

The financial outlook for Cigna Group appears negative due to several key risks affecting its operations. These include potential challenges in accurately pricing healthcare costs, ongoing regulatory scrutiny of pharmacy benefit managers (PBMs), and slow adoption of biosimilars, which could hinder growth in its Evernorth segment. Additionally, rising unemployment may negatively impact commercial membership, and management expresses concerns about significant client attrition and the inability of employers to achieve desired outcomes under new benefit structures.

Cigna (CI) has been analyzed by 15 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 60% recommend Buy, 7% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 15 analysts, Cigna (CI) has a Buy consensus rating as of Oct 14, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $378.27, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $378.27, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.